Thromb Haemost 1959; 03(01): 045-058
DOI: 10.1055/s-0038-1654369
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Prothrombin Time and Hemorrhagic Death in Dicumarolized Rats Receiving Pituitary and Adrenal Hormones[*)]

H van Cauwenberge**
1   Department of Physiology and Pharmacology, University of Saskatchewan, Saskatoon, Canada
,
L. B Jaques
1   Department of Physiology and Pharmacology, University of Saskatchewan, Saskatoon, Canada
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
08. Juni 2018 (online)

 

Summary

1. Rats receiving dicumarol were given injections of desoxycorticosterone, cortisone, hydrocortisone, ACTH, somatotropin, sodium salicylate, adrenaline, reserpine, histamine, 10% sodium chloride intraperitoneally. A high incidence of hemorrhagic death was observed with desoxycorticosterone, ACTH, STH, sodium salicylate, 10% sodium chloride, histamine, adrenaline, reserpine. Little hemorrhage was observed with cortisone and hydrocortisone.

2. The mortality resulting from 10% sodium chloride stress in dicumarolized rats was not depressed by dial, or phenergan, or pretreatment with cortisone. The mortality was prevented by treatment with vitamin Ki before giving the stress agent.

3. The mean prothrombin time with dicumarol in rats appeared to be increased by the administration of ACTH, sodium salicylate, 10% sodium chloride, desoxycorticosterone, adrenaline and histamine. No modification was observed by cortisone, dial, reserpine. With hydrocortisone — there was an increase the day after giving the steroid, but the prothrombin time was nearly normal 2 days later.

4. Steroids were tested for their ability to protect adrenalectomized rats from hemorrhage with dicumarol. Desoxycorticosterone had no action in this regard. Cortisone and hydrocortisone were effective with cortisone being more active.


 


* Supported by the National Research Council of Canada.


** Holder of N.R.C. Post-Doctorate Fellowship at the University of Saskatchewan, on leave of absence from the Department of Medicine, University of Liege (Prof. J. Roskam).